Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#4185 Primary hepatic neuroendocrine neoplasms – Clinical characteristics and treatment outcomes of a rare disease

Introduction: Liver involvement in Neuroendocrine Neoplasms (NEN) most commonly encompasses metastases from other organs or from an unknown primary. The current WHO classification defines primary hepatic NEN (PHNEN) as a distinct entity. With only few cases of PHNEN reported and difficulty to discern them from hepatic metastases, evidence on optimal management is very limited.

Conference:

Presenting Author:

Authors: Apostolidis L, Kender Z, Flegka V, Winkler E, Krug S,

Keywords: hepatic NEN, liver NEN, PHNEN,

#3890 Intracardiac metastasis in well-differentiated ileal neuroendocrine tumor

Introduction: About 60% of well-differentiated neuroendocrine tumors are diagnosed with metastatic disease, above all with liver involvement. The incidence of myocardial metastasis in patients with metastatic neuroendocrine tumor is less than 4%. These are mostly asymptomatic metastasis, so the diagnosis is often incidental.

Conference:

Presenting Author: Della Torre S

Authors: Della Torre S, Smiroldo V, Cozzi C, Galeassi A, Di Bella S,

Keywords: cardiac metastasis, neuroendocrine tumor,

#3693 Gallium-68 DOTANOC PET/CT in locally advanced/metastatic WHO grade 2 gastroenteropancreatic neuroendocrine tumors – Clinical and prognostic impact in assessing progression free survival

Introduction: Ga-68 DOTANOC PET/CT based prognostic factors can help in risk-stratification of patients with locally advanced/metastatic GEP-NETs.

Conference:

Presenting Author:

Authors: Dev I, Rangarajan V, Purandare N, Agrawal A, Shah S,

Keywords: Ga-68 DOTANOC, PET/CT, Grade 2 NET, SUVmax, liver involvement,

#2935 Prior Surgical Resection and Ga-68-DOTANOC PET/CT Imaging-Based Parameters: Do These Impact Outcomes in Grade II Gastroentero-Pancreatic Neuroendocrine Tumors (GEP-NETs)

Introduction: Grade 2 GEP-NETs have inherent tumor heterogeneity seen with positive expression of somatostatin (SSTR) and glucose (GLUT) receptors. Prior surgical resection and imaging parameters on Ga-68 DOTANOC PET/C are well-established variable impacting prognosis in well-differentiated grade 1 NETs. Since the degree of differentiation is variable in Grade 2 NETs, these parameters have not been studied.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Puranik A

Authors: Puranik A, Agrawal A, Rangarajan V, Shrikhande S, Dev I,

Keywords: Grade 2, GEP-NET, DOTANOC, surgical resection,

#2274 Liver Resection for Neuroendocrine Tumors Liver Metastases in Transplantable Patients within the Milan Criteria

Introduction: Liver transplantation (LT) has been prosed as a curative treatment for metastatic gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) but there is a lack of consensus on its real benefit when compared with hepatectomy.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Ruzzenente A

Authors: Ruzzenente A, Bagante F, Aldrighetti L, Ercolani G, Giuliante F,

Keywords: Surgery, Liver Metastases, Hepatectomy,